In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Analyst Joseph Pantginis of H.C. Wainwright maintained a Buy rating on Palatin Technologies (PTN – Research Report), retaining the price ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

But if a company has been paying dividends for a long time, that can give investors confidence in its ability to continue ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

We really do need more tools in the toolbox.” GLP-1 drugs — the class of medication that includes semaglutide and other ...

Eli Lilly ( LLY -1.63%) and Microsoft ( MSFT 1.20%) are two high-flying dividend stocks in the S&P 500 index. Here's why the ...

Tirzepatide is the active ingredient in Mounjaro and Zepbound ... Cost is another thing you may want to factor into the ...